Tailored Management of Advanced Esophageal Squamous Cell Carcinoma — Balancing Efficacy and Toxicity with a “Hold Chemotherapy and Keep Immunotherapy” Strategy: A Case Report
Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with a poor prognosis in advanced stages. Pivotal trials including ATTRACTION-3, CheckMate 648, and CheckMate 577 have demonstrated that immunotherapy with nivolumab significantly improved survival and maintained disease control....
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Journal of Cancer Research and Practice |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ejcrp.eJCRP-D-25-00007 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|